Management of Wide‑Complex Tachycardia (WCT)

Immediate Management of Hemodynamically Unstable WCT

• Perform immediate synchronized cardioversion without awaiting drugs or additional diagnostics in any patient showing hypotension, altered mental status, chest pain, acute heart failure, or shock. Class I recommendation (American Heart Association). 1
• A pre‑cordial thump may be employed only for a witnessed, monitored unstable ventricular tachycardia when a defibrillator is not immediately available. Class IIb (American Heart Association). 1

Diagnostic Assessment in Hemodynamically Stable WCT

• Obtain a 12‑lead ECG during the tachycardia episode as the first step in evaluation. Class I (American Heart Association). 2
• Assess rhythm regularity on the ECG to differentiate regular/monomorphic from irregular/polymorphic patterns. Class I (American Heart Association). 1
• Review prior ECGs for QT‑interval prolongation, which influences drug selection. Class I (American Heart Association). 1
• After stabilization, perform a transthoracic echocardiogram to evaluate ventricular function and structural heart disease. Class I (American Heart Association). 2

Pharmacologic Therapy for Regular (Monomorphic) Stable WCT

Pharmacologic Therapy for Irregular/Polymorphic Stable WCT

• If QT prolongation (torsades de pointes) is present – administer IV magnesium sulfate 2 g as the primary treatment (no specific class rating provided).
• If QT is normal and ischemic VT is suspected – IV amiodarone may be used (Class IIb) and IV β‑blockers can be added to reduce recurrence (Class IIb). 1

Contraindicated Therapies in WCT of Unknown Origin

• Calcium‑channel blockers (verapamil, diltiazem) – can cause hemodynamic collapse if the rhythm is ventricular tachycardia. Class III (American Heart Association & ACC). [1][3]
• β‑blockers – should not be given in hypotensive states. Class III (American Heart Association). 1
• Adenosine – should not be used for irregular or polymorphic wide‑complex tachycardia. Class III (American Heart Association). 1
• Combined IV calcium‑channel blocker + β‑blocker – potentiates hypotension and bradycardia. Class III (ACC). 3
• Use of multiple anti‑arrhythmic agents without expert consultation – discouraged. Class III (American Heart Association). 1

Post‑Stabilization Care and Disposition

• Admit all patients with WCT to an intensive‑care or coronary‑care unit for continuous telemetry and frequent blood‑pressure checks.
• Obtain immediate cardiology/electrophysiology consultation. Class I (ACC). 3
• Plan for electrophysiology study and possible catheter ablation once the patient is stable. Class I (ACC). 3

All bullet points are derived from cited guideline statements and include the strength of recommendation where provided.

Management of Hypotensive Wide Complex Tachycardia

Immediate Interventions

• The American Heart Association recommends immediate synchronized cardioversion for unstable tachycardia with hypotension, which is a Class I recommendation 4, 5, 6, 7
• Prepare for immediate synchronized cardioversion, which is a Class I recommendation for unstable tachycardia with hypotension 4, 7
• Sedate the patient if conscious and time permits, considering etomidate 0.2-0.3 mg/kg IV given hypotension 8, 9
• Have a defibrillator at bedside with pads applied 5
• Consider precordial thump for witnessed, monitored unstable VT, which is a Class IIb recommendation 5, 6

Monitoring and Access

• The American College of Cardiology recommends continuous cardiac monitoring with telemetry 7
• Establish two large-bore IV lines (18-gauge or larger) 7
• Use continuous blood pressure monitoring and consider an arterial line if the patient remains unstable 7
• Monitor pulse oximetry with supplemental oxygen to maintain SpO2 >94% 7
• Obtain a 12-lead ECG immediately, but do not delay cardioversion for this 5, 6, 7

Medication Orders

• The American Heart Association recommends amiodarone 150 mg IV over 10 minutes for wide complex tachycardia with hypotension/heart failure 5, 6, 9
• Procainamide is a Class IIa recommendation for stable wide complex tachycardia 4, 5, 9
• Sotalol 1.5 mg/kg IV over 5 minutes is a Class IIb recommendation, but avoid if QT is prolonged 4, 5
• Do not give adenosine, verapamil, or diltiazem for wide complex tachycardia unless definitively proven SVT 4, 5, 7, 8
• Do not give beta-blockers in a hypotensive state 4, 9

Diagnostic Workup

• The American College of Cardiology recommends stat electrolytes (K+, Mg2+, Ca2+) and correct abnormalities immediately 5
• Check troponin, BNP, complete blood count, and renal function (creatinine, BUN) 4, 5
• Perform a portable chest X-ray to assess for heart failure and structural abnormalities 5
• Consider an echocardiogram once the patient is stabilized to assess ventricular function and structural disease 9

Monitoring Parameters

• The American Heart Association recommends continuous telemetry monitoring 5
• Monitor blood pressure every 5 minutes until stable, then every 15 minutes 5
• Check hourly urine output (target >0.5 mL/kg/hr) 7
• Perform serial 12-lead ECGs (baseline, post-intervention, then every 4-6 hours) 7

Disposition and Consultation

• The American College of Cardiology recommends ICU/CCU admission for all patients with unstable wide complex tachycardia 5, 6
• Immediate cardiology/electrophysiology consultation is required for all wide complex tachycardia of unknown etiology 8, 9, 7
• Consider an electrophysiology study and possible ablation once the patient is stabilized 8, 9